Pricing Log in Create free account
Saturday 17 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

432.49 1.54 −0.35%
Market cap
$234.7B
P/E
26.7×
Fwd P/E
22.7×
Dividend yield
2.30%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Amgen Inc. (AMGN) Current ratio

Alert me on Current ratio

Amgen Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.4×, up 0.2× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 1.1× (fiscal 2025) to 5.5× (fiscal 2017) — the current reading is the lowest in ten years. That is in line with the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.1× (9.29%)
FY2024 1.3× (23.79%)
FY2023 1.6× 16.61%
FY2022 1.4× (11.11%)
FY2021 1.6× (12.32%)
FY2020 1.8× 26.30%
FY2019 1.4× (48.49%)
FY2018 2.8× (49.15%)
FY2017 5.5× 33.57%
FY2016 4.1× (7.62%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.4× 8.69%
Mar 2026 1.3× 10.64%
Dec 2025 1.1× (10.92%)
Sep 2025 1.3× (1.98%)
42 more quarters

Against its own ten years

Low 1.1× High 5.5×
Ten-year median 1.6×
Current reading's percentile 9

Current ratio against peers

Company Current ratio
BMY Bristol Myers Squibb Company compare 1.5×
AMGN Amgen Inc. 1.4×
MRK Merck & Co., Inc. compare 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
NVS Novartis AG compare 0.9×
ABBV AbbVie Inc. compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on AMGN